ArticleEuropean heart journal2026

AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome.

Saranda Nimani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.